Acta Clin Croat
- GLAVCIC M, Cudina I, Hrabac P, Glavcic G, et al
UROTHELIAL CARCINOMA BEFORE AND DURING THE COVID-19 PANDEMIC IN CROATIA - A
SINGLE-CENTER STUDY.
Acta Clin Croat. 2023;62.
- VIDOSAVLJEVIC M, Puntaric D, Gvozdic V, Vidosavljevic D, et al
ARSENIC IN DRINKING WATER AND URINE AND ITS RELATIONSHIP WITH MALIGNANT TUMORS OF
URINARY TRACT IN OSIJEK-BARANJA COUNTY, CROATIA.
Acta Clin Croat. 2023;62.
- CIKIC B, Zekulic T, Penezic L, Andelic J, et al
OPEN RADICAL CYSTECTOMY: SINGLE CENTER RESULTS AND OUTCOMES IN THE LAST FIVE
YEARS.
Acta Clin Croat. 2023;62.
Aging (Albany NY)
- XU J, Chen R, Yang Y, Xu S, et al
Genetically predicted 91 circulating inflammatory proteins in relation to risk of
urological malignancies: a Mendelian randomization study.
Aging (Albany NY). 2024;16:10366-10379.
Asian J Endosc Surg
- WATANABE S, Kobayashi H, Hiroe N, Iwasawa T, et al
Robot-assisted radical cystectomy for bladder cancer after low anterior
resection: A case report.
Asian J Endosc Surg. 2024;17:e13345.
- NARA T, Numakura K, Furihata K, Kikuchi A, et al
Arterio-ureteral fistula from a pseudoaneurysm of the right common iliac artery
after robot-assisted laparoscopic radical cystectomy: A case report.
Asian J Endosc Surg. 2024;17:e13348.
Biochem Genet
- LE M, Qing M, Zeng X, Cheng S, et al
m6A-YTHDF1 Mediated Regulation of GRIN2D in Bladder Cancer Progression and
Aerobic Glycolysis.
Biochem Genet. 2024 Jun 29. doi: 10.1007/s10528-024-10875.
Biomed J
- CHEN ST, Chang KS, Lin WY, Hsu SY, et al
Activating transcription factor 3 is an antitumor gene synergizing with growth
differentiation factor 15 to modulate cell growth in human bladder cancer.
Biomed J. 2024 Jun 26:100756. doi: 10.1016/j.bj.2024.100756.
BJU Int
- ANTONELLI L, Wendel-Garcia PD, Deforth M, Afferi L, et al
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces
thromboembolism and bleeding.
BJU Int. 2024 Jul 3. doi: 10.1111/bju.16444.
BMC Microbiol
- WANG B, Qiu Y, Xie M, Huang P, et al
Gut microbiota Parabacteroides distasonis enchances the efficacy of immunotherapy
for bladder cancer by activating anti-tumor immune responses.
BMC Microbiol. 2024;24:237.
Can Vet J
- PARK J, Lee SG, Jeong SM, Nam A, et al
Inflammatory myofibroblastic tumor in the urinary bladder in a dog.
Can Vet J. 2024;65:643-648.
Cancer
- MARTINI DJ, Case KB, Gratz D, Pellegrini K, et al
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with
divergent differentiation.
Cancer. 2024 Jul 3. doi: 10.1002/cncr.35465.
- NIERENGARTEN MB
New standard of care for bladder cancer.
Cancer. 2024;130:2407.
Cancer Genomics Proteomics
- NAGATA Y, Quynh NT, Aono H, Harada K, et al
Melatonin Inhibits Chemical Carcinogen-mediated Malignant Transformation of
Urothelial Cells: In Vitro Evidence.
Cancer Genomics Proteomics. 2024;21:388-394.
- SHABBIR R, Telfer BA, Dickie B, Reardon M, et al
Implementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot
Genomic Study of Hypoxia in Bladder Cancer Xenografts.
Cancer Genomics Proteomics. 2024;21:380-387.
Cancer Radiother
- BOUE-RAFLE A, Briens A, Supiot S, Blanchard P, et al
[Does radiation therapy for prostate cancer increase the risk of second
cancers?].
Cancer Radiother. 2024;28:293-307.
Cell Mol Biol Lett
- LIU J, Wang X, Jiang W, Azoitei A, et al
Impairment of alpha-tubulin and F-actin interactions of GJB3 induces aneuploidy in
urothelial cells and promotes bladder cancer cell invasion.
Cell Mol Biol Lett. 2024;29:94.
Clin Genitourin Cancer
- VINICIUS SUARTZ C, Araujo Simoes PA, Doratioto Serrano Faria Braz N, da Silva FR, et al
Surviving the Storm: Challenges of Bladder Cancer Care During the COVID-19
Pandemic.
Clin Genitourin Cancer. 2024;22:102129.
Comb Chem High Throughput Screen
- LI C, Chu G, Ma G, Chen X, et al
SLC16A3 is a Prognostic Marker and Affects Immune Regulation in Bladder Cancer.
Comb Chem High Throughput Screen. 2024.
- JIANG D, Zhang H, Yin B, He M, et al
The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K/AKT
Signaling Pathway.
Comb Chem High Throughput Screen. 2024;27:1984-1998.
Endoscopy
- ALWALI A, Schafmayer C, Kamaleddine I
Combined endoscopic management of a postoperative rectocutaneous fistula after
cystectomy using modified percutaneous endofistular and transanal endoluminal
vacuum therapy.
Endoscopy. 2024;56.
Expert Opin Drug Saf
- PENG Y, Song Y, Du Y, Qin C, et al
Comparative analysis of adverse events among intravesical drugs in bladder
cancer: a real-world study on FAERS database.
Expert Opin Drug Saf. 2024 Jul 4:1-8. doi: 10.1080/14740338.2024.2374921.
Future Oncol
- CHAMIE K, Chang SS, Rosser CJ, Kramolowski E, et al
N-803 Plus BCG Treatment for BCG-Naive or -Unresponsive Non-Muscle Invasive
Bladder Cancer: A Plain Language Review.
Future Oncol. 2024 Jul 2:1-11. doi: 10.1080/14796694.2024.2363744.
Hinyokika Kiyo
- NAGAHAMA K, Ito M, Imai K, Masuda N, et al
[Repair of Vaginal Cuff Dehiscence after Laparoscopic Radical Cystectomy with
Gracilis Myocutaneous Flap].
Hinyokika Kiyo. 2024;70:155-159.
- AKAI T, Ueno S, Takeda A, Tokuyama S, et al
[A Case of Lymphorrhea after Radical Cystectomy Treated by Ultrasound-Guided
Inguinal Intranodal Lymphangiography].
Hinyokika Kiyo. 2024;70:123-127.
- YAMASAKI T, Yoshino T, Kojo K, Kimura T, et al
[Two Cases of Bleeding from the Ileal Conduit Due to Ectopic Varices].
Hinyokika Kiyo. 2024;70:101-106.
- AIGASE T, Tatenuma T, Uemura K, Makiyama K, et al
[A Case of Successful Treatment of Small Cell Carcinoma of the Bladder with
Pembrolizumab].
Hinyokika Kiyo. 2024;70:93-99.
- KIYAMA Y, Sekii Y, Inoguchi S, Matsumura S, et al
[A Case of Primary Adenocarcinoma Mucinous Subtype of the Bladder].
Hinyokika Kiyo. 2024;70:89-92.
- MOROOKA D, Nakajima Y, Tabata H, Hotta H, et al
[A Case of Systemic Wild-Type Transthyretin Amyloid (ATTR) Amyloidosis Diagnosed
in a Patient with Gross Hematuria].
Hinyokika Kiyo. 2024;70:65-69.
Int Cancer Conf J
- TORII S, Narita T, Homma T, Kinoshita T, et al
Successful pre-surgical treatment with carboplatin and gemcitabine chemotherapy
for a patient with muscle-invasive bladder cancer and severe renal dysfunction.
Int Cancer Conf J. 2024;13:230-234.
Int Immunopharmacol
- JIAN Y, Chen Q, Al-Danakh A, Xu Z, et al
Identification and validation of sialyltransferase ST3Gal5 in bladder cancer
through bioinformatics and experimental analysis.
Int Immunopharmacol. 2024;138:112569.
Int J Cancer
- DI BELLO F, Siech C, Jannello LMI, de Angelis M, et al
Contemporary survival in metastatic bladder cancer patients: A population-based
study.
Int J Cancer. 2024 Jul 3. doi: 10.1002/ijc.35077.
- NESIC M, Rasmussen MH, Henriksen TV, Demuth C, et al
Beyond basics: Key mutation selection features for successful tumor-informed
ctDNA detection.
Int J Cancer. 2024;155:925-933.
Int J Pharm
- PEREIRA SANTOS CARVALHO I, Bueno Silva L, Luis Ferraz do Amaral R, Nader Chrysostomo-Massaro T, et al
Evaluation of in vivo and in vitro efficacy of solasonine/solamargine-loaded
lipid-polymer hybrid nanoparticles against bladder cancer.
Int J Pharm. 2024 Jul 1:124411. doi: 10.1016/j.ijpharm.2024.124411.
Int J Urol
- ASAKAWA K, Waratani M, Massey O, Holbrook T, et al
Real-world epidemiology and treatment patterns of patients with locally advanced
or metastatic urothelial carcinoma: Retrospective analysis of Diagnosis Procedure
Combination claims data in Japan.
Int J Urol. 2024;31:730-738.
- HATTORI Y, Fujiwara T, Hagimoto H, Kokubun H, et al
Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant
chemotherapy for muscle-invasive bladder cancer.
Int J Urol. 2024 Jul 3. doi: 10.1111/iju.15524.
- YASUDA Y, Numao N, Fujiwara R, Takemura K, et al
Surgical outcomes and predictive value for major complications of robot-assisted
radical cystectomy of real-world data in a single institution in Japan.
Int J Urol. 2024;31:724-729.
Int Neurourol J
- SEOK J, Kwak Y, Kim S, Kim EM, et al
Advances in Liquid Biopsy for Diagnosis of Bladder Cancer.
Int Neurourol J. 2024;28:83-95.
J Clin Invest
- LI W, Chen C, Zheng H, Lin Y, et al
UBE2C-induced crosstalk between mono- and polyubiquitination of SNAT2 promotes
lymphatic metastasis in bladder cancer.
J Clin Invest. 2024;134:e179122.
J Clin Oncol
- KLUMPER N, Tran NK, Zschabitz S, Hahn O, et al
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin
Response in Metastatic Urothelial Cancer.
J Clin Oncol. 2024;42:2446-2455.
J Pak Med Assoc
- SAEED S, Khan D, Faisal S, Rauf F, et al
A histopathological and epidemiological study of urothelial carcinoma at a
tertiary care centre in Peshawar, Pakistan.
J Pak Med Assoc. 2024;74:1160-1162.
J Robot Surg
- FUKATA S, Kawaguchi A, Yoshimura R, Fukuhara H, et al
Investigation of risk factors for vaginal dehiscence and development of small
bowel evisceration after robot-assisted radical cystectomy for female bladder
cancer and an improved vaginal reconstruction technique to prevent its onset.
J Robot Surg. 2024;18:276.
- CELLA L, Basile G, Moretto S, Paciotti M, et al
Robotic assisted vs open radical cystectomy: an updated systematic review and
meta-analysis.
J Robot Surg. 2024;18:277.
J Transl Med
- YANG Z, Chen Q, Dong S, Xu P, et al
Hypermethylated TAGMe as a universal-cancer-only methylation marker and its
application in diagnosis and recurrence monitoring of urothelial carcinoma.
J Transl Med. 2024;22:608.
J Urol
- DINNEY CPN, Narayan VM
Reply: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With
Bacillus Calmette-Guerin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year
Follow-Up From a Phase 3 Trial.
J Urol. 2024 Jul 5:101097JU0000000000004128. doi: 10.1097/JU.0000000000004128.
Life Sci
- CHEN H, Cai Z, Dong X, Chen W, et al
Cigarette smoking-related OLC1 overexpression associated with poor prognosis in
bladder urothelial carcinoma.
Life Sci. 2024;351:122821.
Medicine (Baltimore)
- YANG X, Zhang Y, Liu J, Feng Y, et al
Construction and validation of a prognostic model for bladder cancer based on
disulfidptosis-related lncRNAs.
Medicine (Baltimore). 2024;103:e38750.
Minerva Urol Nephrol
- PETRELLA G, Ciufolini G, Lentini S, Montorsi F, et al
The grade of systemic inflammation, immune inhibition, and gut dysbiosis as
prognostic factors for bladder cancer recurrence: a metabolomics approach.
Minerva Urol Nephrol. 2024 Jul 1. doi: 10.23736/S2724-6051.24.05747.
Mol Ther Oncol
- PAPADIMITRIOU MA, Pilala KM, Panoutsopoulou K, Levis P, et al
CDKN2A copy number alteration in bladder cancer: Integrative analysis in
patient-derived xenografts and cancer patients.
Mol Ther Oncol. 2024;32:200818.
Nat Med
- LI R, Shah PH, Stewart TF, Nam JK, et al
Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in
BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.
Nat Med. 2024 Jul 2. doi: 10.1038/s41591-024-03157.
Nat Prod Res
- HOSSEINI SA
The therapeutic effect of baicalin in the treatment of bladder cancer: a
mini-review.
Nat Prod Res. 2024 Jul 2:1-5. doi: 10.1080/14786419.2024.2373955.
Nat Rev Urol
- SANTONI M, Takeshita H, Massari F, Bamias A, et al
Pembrolizumab plus enfortumab vedotin in urothelial cancer.
Nat Rev Urol. 2024;21:387-388.
- LLOYD L
The bladder tumour microbiome and BCG response.
Nat Rev Urol. 2024;21:389.
- SMITH DJ, Lunj S, Adamson AD, Nagarajan S, et al
CRISPR-Cas9 potential for identifying novel therapeutic targets in
muscle-invasive bladder cancer.
Nat Rev Urol. 2024 Jul 1. doi: 10.1038/s41585-024-00901.
Oncologist
- PICHLER R, Fritz J, Mari A, Cadenar A, et al
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive
bladder cancer undergoing radical cystectomy.
Oncologist. 2024 Jul 2:oyae160. doi: 10.1093.
Oncology
- NAKAMURA K, Ohno T, Inamoto T, Takai T, et al
Pattern of Expression of MicroRNA in Patients with Radiation-Induced Bladder
Injury.
Oncology. 2024;102:585-592.
Sci Rep
- SAIZONOU I, Lascombe I, Monnien F, Bedgedjian I, et al
Concomitant decrease of E- and A-FABP expression predicts worse survival in
urothelial bladder cancer patients.
Sci Rep. 2024;14:15390.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016